- Liu, Kathleen;
- Hsu, Chi-Yuan;
- Liu, KD;
- Yang, W;
- Anderson, AH;
- Feldman, HI;
- Demirjian, S;
- Hamano, T;
- He, J;
- Lash, J;
- Lustigova, E;
- Rosas, SE
Novel biomarkers may improve our ability to predict which patients with chronic kidney disease (CKD) are at higher risk for progressive loss of renal function. Here, we assessed the performance of urine neutrophil gelatinase-associated lipocalin (NGAL) for
